Spots Global Cancer Trial Database for ph+ acute lymphoblastic leukemia
Every month we try and update this database with for ph+ acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL) | NCT01207440 | Chronic Myeloid... Ph+ Acute Lymph... | Ponatinib | 18 Years - | Takeda | |
Nilotinib Pre and Post Allogeneic Stem Cell Transplantation | NCT00750659 | Chronic Myeloid... Acute Lymphobla... Stem Cell Trans... | Nilotinib | 18 Years - 65 Years | Sheba Medical Center | |
Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients | NCT02690922 | ph+ Acute Lymph... | Dasatinib prednisone dexamethasone methotrexate | 18 Years - | Tongji Hospital | |
Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients | NCT02690922 | ph+ Acute Lymph... | Dasatinib prednisone dexamethasone methotrexate | 18 Years - | Tongji Hospital | |
Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL) | NCT01207440 | Chronic Myeloid... Ph+ Acute Lymph... | Ponatinib | 18 Years - | Takeda | |
Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients | NCT02690922 | ph+ Acute Lymph... | Dasatinib prednisone dexamethasone methotrexate | 18 Years - | Tongji Hospital |